Part 2: Narelle Smith and Professor Gordon Cook continue their discussion on the use of Autologous Stem Cell Transplant (AuSCT) in treating myeloma. This episode covers the key differences between AuSCT, allogeneic stem cell transplant, and CAR-T cell therapy, and concludes with a look at the role of maintenance therapy following an AuSCT.
All content for MyeConversations by Myeloma Australia is the property of Myeloma Australia and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Part 2: Narelle Smith and Professor Gordon Cook continue their discussion on the use of Autologous Stem Cell Transplant (AuSCT) in treating myeloma. This episode covers the key differences between AuSCT, allogeneic stem cell transplant, and CAR-T cell therapy, and concludes with a look at the role of maintenance therapy following an AuSCT.
S01 E05: Complementary, Alternative and Integrative Medicine (CAM) a case study
MyeConversations by Myeloma Australia
33 minutes
3 years ago
S01 E05: Complementary, Alternative and Integrative Medicine (CAM) a case study
We are joined by our special guest Gail Rowan, senior pharmacist at Peter MacCallum Cancer Centre. In this episode Gail talks to us about everything complementary and alternative medicines (CAM) and presents a case study from her clinic. Gail explains the difference between complementary and alternate medicines and discusses the importance of speaking to the health care team if using complementary therapies in conjunction with myeloma therapies.
MyeConversations by Myeloma Australia
Part 2: Narelle Smith and Professor Gordon Cook continue their discussion on the use of Autologous Stem Cell Transplant (AuSCT) in treating myeloma. This episode covers the key differences between AuSCT, allogeneic stem cell transplant, and CAR-T cell therapy, and concludes with a look at the role of maintenance therapy following an AuSCT.
